Famotidine |
Pepcid AC; Pepcid Oral |
Famotidine Systematic (IUPAC) name 2-[4-[2-(amino-sulfamoylimino-methyl) ethylsulfanylmethyl]-1,3-thiazol-2-yl]guanidine Identifiers CAS number 76824-35-6 ATC code A02BA03 PubChem 3325 DrugBank APRD00296 Chemical data Formula C8H15N7O2S3 Mol. weight 337.449 g/mol Pharmacokinetic data Bioavailability 20–66% Protein binding 10–28% Metabolism Hepatic Half life 2.6–4 hours Excretion Renal 20–70%, faecal 50% Therapeutic considerations Pregn ...
Wikipedia - [full article]
Famotidine Clinical Trials
- Famotidine in Subjects with Non-Erosive Gastroesophageal Reflux Disease
ClinicalTrials.gov Identifier: NCT00141960 - Completed
Gastroesophageal Reflux; Gastrointestinal Diseases; Reflux, Gastroesophageal; GERD
- Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
ClinicalTrials.gov Identifier: NCT00365339 - Completed
HIV Infections
- Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00384904 - Completed
HIV Infections
- Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
ClinicalTrials.gov Identifier: NCT00229424 - Completed
Gastroesophageal Reflux

Not Signed In -


